The Globe and Mail (Prairie Edition) - - LEADING EDGE - Marjo Johne

Head­quar­ters: Smiths Falls, Ont.

In busi­ness since: 2014 Em­ploy­ees: 1,800 Rev­enue: $40-mil­lion in 2017

Mar­i­juana com­pa­nies tend to elicit jokes about high profit mar­gins. But at Canopy Growth Corp., cannabis is a se­ri­ous, science-based busi­ness, its chief says. North Amer­ica’s first pub­licly traded cannabis com­pany – and Canada’s largest med­i­cal mar­i­juana pro­ducer – has built a cred­i­ble en­ter­prise by fo­cus­ing on con­sis­tency in its prod­ucts and strict ad­her­ence to sci­en­tific pro­to­cols.

In ad­di­tion to its first-to-thes-tock-ex­change sta­tus, the com­pany boasts other firsts in its in­dus­try, says Bruce Lin­ton, founder and co-CEO of Canopy, which has two di­vi­sions, med­i­cal and recre­ational, with busi­nesses span­ning from green­houses and man­u­fac­tur­ing to on­line and bricks-and-mor­tar re­tail.

The com­pany has grown its foot­print and di­ver­si­fied its op­er­a­tions through in­ter­nal ex­pan­sion and part­ner­ships with other in­dus­try play­ers.

Canopy re­cently be­came first to legally ex­port cannabis to the United States, where it will be used for med­i­cal re­search, says Mr. Lin­ton. Canopy is also an ac­tive ed­u­ca­tor, of­fer­ing pro­grams to Cana­dian doc­tors.

With recre­ational mar­i­juana soon to be le­gal in Canada, Canopy is po­si­tioned to be­come the dom­i­nant player in the cannabis in­dus­try, says Mr. Lin­ton. The firm of­fers a range of brands and cannabis strains in var­i­ous forms that in­clude dried, oil and soft-gel cap­sules.

Newspapers in English

Newspapers from Canada

© PressReader. All rights reserved.